Stay updated with breaking news from Recombinant Human. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sino Biological has the capability to produce GMP-grade cytokines which can play huge roles into cell therapy and clinical applications research.
A polypeptide known as human epidermal growth factor (EGF) binds to the receptor EGFR, which triggers a series of reactions that activate gene pathways
Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on angiotensin-converting enzyme inhibitor
Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on...
Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka. The commercial production in the SML was started in November 1989. Today SML, with a consolidated revenue of R 1,159.76 crore for the year 2021-22 against the previous years’ revenue of Rs 931.27 crore, has emerged as a global brand within manufacturing and supplying of affordable API and Formulation globally in different regulated markets. The Group with over 20 subsidiaries is now setting up a greenfield project located in Karnataka. BioSpectrum India spoke to Vishnukant Bhutada...